Global 2023 - Players, Regions, Product Types, Application & Forecast Analysis
收藏theindustrystats.com2025-03-26 收录
下载链接：
https://theindustrystats.com/report/inhalation-nasal-spray-generic-drug-market/10298/?utm_source=google&utm_medium=datasets&utm_campaign=datasetsearch
下载链接
链接失效反馈官方服务：
资源简介：
Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period<table class='table'> <tr> <th>ATTRIBUTES</th> <th>DETAILS</th> </tr><tr> <td>STUDY PERIOD</td><td>2017-2030</td></tr><tr> <td>BASE YEAR</td><td>2023</td></tr><tr> <td>FORECAST PERIOD</td><td>2024-2030</td></tr><tr> <td>HISTORICAL PERIOD</td><td>2017-2022</td></tr><tr> <td>UNIT</td><td>VALUE (USD MILLION)</td></tr><tr> <td>KEY COMPANIES PROFILED</td><td>Teva, Sandoz (Novartis), Mylan, Allergan PLC, Cipla, Akorn, Apotex, Bayer, GlaxoSmithKline, Catalent, Pfizer, Innovus Pharmaceuticals, Sunovion Pharmaceuticals, Nephron Pharmaceuticals, Sun Pharma (Ranbaxy), Beximco Pharma, Hikma (Roxane), Adapt Pharma, XIANJU PHARMA, J Pharmaceuticals</td></tr><tr> <td>SEGMENTS COVERED</td><td style='text-transform:capitalize;'>By Product Type - Corticosteroids, Bronchodilators, Combinations, Decongestant Sprays, Others<br>By Application - Asthma, COPD, Allergic Rhinitis, Others<br>By Sales Channels - Direct Channel, Distribution Channel<br>By Geography - North America, Europe, Asia-Pacific, South America, Middle East and Africa</td></tr></table>
近年来，产品市场体量持续攀升，预计在预测期内将实现显著增长。<table class='table'> <tr> <th>属性</th> <th>详细信息</th> </tr><tr> <td>研究周期</td><td>2017-2030</td></tr><tr> <td>基准年份</td><td>2023</td></tr><tr> <td>预测周期</td><td>2024-2030</td></tr><tr> <td>历史周期</td><td>2017-2022</td></tr><tr> <td>计量单位</td><td>价值（亿美元）</td></tr><tr> <td>主要公司概况</td><td>Teva, Sandoz（诺华），Mylan, Allergan PLC, Cipla, Akorn, Apotex, Bayer, GlaxoSmithKline, Catalent, Pfizer, Innovus Pharmaceuticals, Sunovion Pharmaceuticals, Nephron Pharmaceuticals, Sun Pharma（Ranbaxy），Beximco Pharma, Hikma（Roxane），Adapt Pharma, XIANJU PHARMA, J Pharmaceuticals</td></tr><tr> <td>涵盖的细分市场</td><td style='text-transform:capitalize;'>按产品类型 - 皮质类固醇，支气管扩张剂，组合，去充血剂喷雾，其他<br>按应用 - 哮喘，慢性阻塞性肺病，过敏性鼻炎，其他<br>按销售渠道 - 直接渠道，分销渠道<br>按地理区域 - 北美洲，欧洲，亚太地区，南美洲，中东和非洲</td></tr></table>
提供机构：
theindustrystats.com
